-
1
-
-
0024829663
-
Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors
-
Haskel E.J., Adams S.P., Feigen L.P., Saffitz J.E., Gorczynski R.J., Sobel B.E., Abendschein D.R. Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors. Circulation. 80:1989;1775-1782.
-
(1989)
Circulation
, vol.80
, pp. 1775-1782
-
-
Haskel, E.J.1
Adams, S.P.2
Feigen, L.P.3
Saffitz, J.E.4
Gorczynski, R.J.5
Sobel, B.E.6
Abendschein, D.R.7
-
2
-
-
0025719946
-
A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty
-
Bates E.R., McGillem M.J., Mickelson J.K., Pitt B., Mancini G.B.J. A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty. Circulation. 84:1991;2463-2469.
-
(1991)
Circulation
, vol.84
, pp. 2463-2469
-
-
Bates, E.R.1
McGillem, M.J.2
Mickelson, J.K.3
Pitt, B.4
Mancini, G.B.J.5
-
3
-
-
0026711265
-
Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis
-
Willette R.N., Sauermelch C.F., Rycyna R., Sarkar S., Feuerstein G.Z., Nichols A.J., Ohlstein E.H. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis. Stroke. 23:1992;703-711.
-
(1992)
Stroke
, vol.23
, pp. 703-711
-
-
Willette, R.N.1
Sauermelch, C.F.2
Rycyna, R.3
Sarkar, S.4
Feuerstein, G.Z.5
Nichols, A.J.6
Ohlstein, E.H.7
-
4
-
-
0023877450
-
Effect of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and haemostasis in the baboon
-
Hanson S.R., Pareti F.I., Ruggeri Z.M., Marzec U.M., Kunicki T.J., Montgomery R.R., Zimmerman T.S., Harker L.A. Effect of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and haemostasis in the baboon. J Clin Invest. 81:1988;149-158.
-
(1988)
J Clin Invest
, vol.81
, pp. 149-158
-
-
Hanson, S.R.1
Pareti, F.I.2
Ruggeri, Z.M.3
Marzec, U.M.4
Kunicki, T.J.5
Montgomery, R.R.6
Zimmerman, T.S.7
Harker, L.A.8
-
5
-
-
0024459459
-
RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo: Studies using a baboon model
-
Cadroy Y., Houghten R.A., Hanson S.R. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. studies using a baboon model J Clin Invest. 84:1989;939-944.
-
(1989)
J Clin Invest
, vol.84
, pp. 939-944
-
-
Cadroy, Y.1
Houghten, R.A.2
Hanson, S.R.3
-
6
-
-
0029021390
-
Prolonged inhibition of acute arterial thrombosis by high dosing of a monoclonal anti-platelet glycoprotein IIb/IIIa antibody in a baboon model
-
Kotzé H.F., Badenhorst P.N., Lamprecht S., Meiring M., Van Wyk V., Nuyts K., Stassen J.M., Vermylen J., Deckmyn H. Prolonged inhibition of acute arterial thrombosis by high dosing of a monoclonal anti-platelet glycoprotein IIb/IIIa antibody in a baboon model. Thromb Haemost. 74:1995;751-757.
-
(1995)
Thromb Haemost
, vol.74
, pp. 751-757
-
-
Kotzé, H.F.1
Badenhorst, P.N.2
Lamprecht, S.3
Meiring, M.4
Van Wyk, V.5
Nuyts, K.6
Stassen, J.M.7
Vermylen, J.8
Deckmyn, H.9
-
7
-
-
0344221432
-
Inhibition of platelet function with synthetic peptides designed to be high affinity antagonists of fibrinogen binding to platelets
-
Ruggeri Z.M., Houghton R.A., Russel S.R., Zimmerman T.S. Inhibition of platelet function with synthetic peptides designed to be high affinity antagonists of fibrinogen binding to platelets. Proc Natl Acad Sci USA. 83:1986;5708-5712.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 5708-5712
-
-
Ruggeri, Z.M.1
Houghton, R.A.2
Russel, S.R.3
Zimmerman, T.S.4
-
8
-
-
0001484909
-
Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-propyl-L-arginyl chloromethyl ketone
-
Hanson S.R., Harker L.A. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-propyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci USA. 85:1988;3184-3188.
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 3184-3188
-
-
Hanson, S.R.1
Harker, L.A.2
-
9
-
-
0029072939
-
A four-hour infusion of recombinant hirudin results in long-term inhibition of arterial-type thrombosis in baboons
-
Kotzé H.F., Lamprecht S., Badenhorst P.N. A four-hour infusion of recombinant hirudin results in long-term inhibition of arterial-type thrombosis in baboons. Blood. 85:1995;3158-3163.
-
(1995)
Blood
, vol.85
, pp. 3158-3163
-
-
Kotzé, H.F.1
Lamprecht, S.2
Badenhorst, P.N.3
-
10
-
-
0024556368
-
Inhibition of platelet dependent thrombus formation by human activated protein C in a primate model
-
Gruber A., Griffen J.H., Harker L.A., Hanson S.R. Inhibition of platelet dependent thrombus formation by human activated protein C in a primate model. Blood. 73:1989;639-642.
-
(1989)
Blood
, vol.73
, pp. 639-642
-
-
Gruber, A.1
Griffen, J.H.2
Harker, L.A.3
Hanson, S.R.4
-
11
-
-
0025737202
-
Prevention of arterial reocclusion after thrombolysis with recombinant lipo-protein-associated coagulation inhibitor
-
Haskel E.J., Torr S.R., Day K.C., Palmier M.O., Wun T.C., Sobel B.E., Abendschein D.R. Prevention of arterial reocclusion after thrombolysis with recombinant lipo-protein-associated coagulation inhibitor. Circulation. 84:1991;821-827.
-
(1991)
Circulation
, vol.84
, pp. 821-827
-
-
Haskel, E.J.1
Torr, S.R.2
Day, K.C.3
Palmier, M.O.4
Wun, T.C.5
Sobel, B.E.6
Abendschein, D.R.7
-
12
-
-
0030811328
-
Transient interruption of arterial thrombosis by inhibition of factor Xa results in long-term antithrombotic effects in baboons
-
Kotzé H.F., Lamprecht S., Badenhorst P.N., Roodt J.P., Van Wyk V. Transient interruption of arterial thrombosis by inhibition of factor Xa results in long-term antithrombotic effects in baboons. Thromb Haemost. 77:1997;1137-1142.
-
(1997)
Thromb Haemost
, vol.77
, pp. 1137-1142
-
-
Kotzé, H.F.1
Lamprecht, S.2
Badenhorst, P.N.3
Roodt, J.P.4
Van Wyk, V.5
-
14
-
-
0025951849
-
Chimeric antithrombin peptide: Characterization of an Arg-Gly-Asp (RGD)- And hirudin carboxyl terminus-containing synthetic peptide
-
Church F.C., Phillips J.E., Woods J.L. Chimeric antithrombin peptide. characterization of an Arg-Gly-Asp (RGD)- and hirudin carboxyl terminus-containing synthetic peptide J Biol Chem. 266:1991;11975-11979.
-
(1991)
J Biol Chem
, vol.266
, pp. 11975-11979
-
-
Church, F.C.1
Phillips, J.E.2
Woods, J.L.3
-
15
-
-
0033558011
-
Insertion of the Asp-Ser-Phe sequence in the P'position of hirutonin provides molecules having both antithrombin and disintegrin activity
-
Leblond L., DiMaio J., Winocour P.D. Insertion of the Asp-Ser-Phe sequence in the P'position of hirutonin provides molecules having both antithrombin and disintegrin activity. Thromb Res. 93:1999;171-181.
-
(1999)
Thromb Res
, vol.93
, pp. 171-181
-
-
Leblond, L.1
Dimaio, J.2
Winocour, P.D.3
-
16
-
-
0028255957
-
Covalent linkage of streptokinase to recombinant hirudin: A novel thrombolytic agent with antithrombotic properties
-
Phaneuf M.D., Ozaki C.K., Johnstone M.T., Loza J.-P., Quist W.C., LoGerfo F.W. Covalent linkage of streptokinase to recombinant hirudin. a novel thrombolytic agent with antithrombotic properties Thromb Haemost. 71:1994;481-487.
-
(1994)
Thromb Haemost
, vol.71
, pp. 481-487
-
-
Phaneuf, M.D.1
Ozaki, C.K.2
Johnstone, M.T.3
Loza, J.-P.4
Quist, W.C.5
Logerfo, F.W.6
-
17
-
-
0028892095
-
Functional properties of a recombinant chimeric protein with combined thrombin inhibitory and plasminogen-activating potential
-
Lijnen H.R., Wendt S., Schneider J., Janocha E., Van Hoef B., Collen D., Steffeus G.J. Functional properties of a recombinant chimeric protein with combined thrombin inhibitory and plasminogen-activating potential. Eur J Biochem. 234:1995;350-357.
-
(1995)
Eur J Biochem
, vol.234
, pp. 350-357
-
-
Lijnen, H.R.1
Wendt, S.2
Schneider, J.3
Janocha, E.4
Van Hoef, B.5
Collen, D.6
Steffeus, G.J.7
-
18
-
-
0030581628
-
Integrin-specific tissue-type plasminogen activator engineered by introduction of the Arg-Gly-Pro sequence
-
Yamada T., Shimada Y., Kikuchi M. Integrin-specific tissue-type plasminogen activator engineered by introduction of the Arg-Gly-Pro sequence. Biochem Biophys Res Commun. 228:1996;306-311.
-
(1996)
Biochem Biophys Res Commun
, vol.228
, pp. 306-311
-
-
Yamada, T.1
Shimada, Y.2
Kikuchi, M.3
-
19
-
-
0031432460
-
Production of a recombinant antithrombotic and fibrinolytic protein, PLATSAK, in Escherichia coli.
-
Van Zyl W.B., Pretorius G.H.J., Hartmann M., Kotzé H.F. Production of a recombinant antithrombotic and fibrinolytic protein, PLATSAK, in Escherichia coli. Thromb Res. 88:1997;419-426.
-
(1997)
Thromb Res
, vol.88
, pp. 419-426
-
-
Van Zyl, W.B.1
Pretorius, G.H.J.2
Hartmann, M.3
Kotzé, H.F.4
-
20
-
-
0028261051
-
Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential?
-
Collen D., Lijnen H.R. Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential? Blood. 84:1994;680-686.
-
(1994)
Blood
, vol.84
, pp. 680-686
-
-
Collen, D.1
Lijnen, H.R.2
-
21
-
-
0023637601
-
New perspectives in cell adhesion: RGD and integrins
-
Ruoslahti E., Pierschbacher M.D. New perspectives in cell adhesion. RGD and integrins Science. 238:1987;491-497.
-
(1987)
Science
, vol.238
, pp. 491-497
-
-
Ruoslahti, E.1
Pierschbacher, M.D.2
-
22
-
-
0026657151
-
The structure of residues 7-16 of the Aα-chain of human fibrinogen bound to bovine thrombin at 2.3Å resolution
-
Martin P.D., Robertson W., Turk D., Huber R., Bode W., Edwards B.F.P. The structure of residues 7-16 of the Aα-chain of human fibrinogen bound to bovine thrombin at 2.3Å resolution. J Biol Chem. 267:1992;7911-7920.
-
(1992)
J Biol Chem
, vol.267
, pp. 7911-7920
-
-
Martin, P.D.1
Robertson, W.2
Turk, D.3
Huber, R.4
Bode, W.5
Edwards, B.F.P.6
-
23
-
-
0000319455
-
Hirudin as an inhibitor of thrombin
-
Markwardt F. Hirudin as an inhibitor of thrombin. Methods Enzymol. 19:1970;924-932.
-
(1970)
Methods Enzymol
, vol.19
, pp. 924-932
-
-
Markwardt, F.1
-
24
-
-
0022401020
-
Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons
-
Hanson S.R., Kotzé H.F., Savage B., Harker L.A. Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Arteriosclerosis. 5:1985;595-603.
-
(1985)
Arteriosclerosis
, vol.5
, pp. 595-603
-
-
Hanson, S.R.1
Kotzé, H.F.2
Savage, B.3
Harker, L.A.4
-
25
-
-
0023622165
-
Baboon models of acute arterial thrombosis
-
Hanson S.R., Harker L.A. Baboon models of acute arterial thrombosis. Thromb Haemost. 58:1987;801-805.
-
(1987)
Thromb Haemost
, vol.58
, pp. 801-805
-
-
Hanson, S.R.1
Harker, L.A.2
-
26
-
-
0024603495
-
Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo
-
Cadroy Y., Horbett T.A., Hanson S.R. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo. J Lab Clin Med. 113:1989;436-448.
-
(1989)
J Lab Clin Med
, vol.113
, pp. 436-448
-
-
Cadroy, Y.1
Horbett, T.A.2
Hanson, S.R.3
-
27
-
-
0028583118
-
Recombinant proteins can be isolated from E. coli cells by repeated cycles of freezing and thawing
-
Johnson B.H., Hecht M.H. Recombinant proteins can be isolated from E. coli cells by repeated cycles of freezing and thawing. Biotechnology. 12:1994;1357-1360.
-
(1994)
Biotechnology
, vol.12
, pp. 1357-1360
-
-
Johnson, B.H.1
Hecht, M.H.2
-
29
-
-
0027435111
-
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates
-
Hanson S.R., Griffen J.H., Harker L.A., Kelly A.B., Esmon C.T., Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest. 92:1993;2003-2012.
-
(1993)
J Clin Invest
, vol.92
, pp. 2003-2012
-
-
Hanson, S.R.1
Griffen, J.H.2
Harker, L.A.3
Kelly, A.B.4
Esmon, C.T.5
Gruber, A.6
-
30
-
-
0028045677
-
Strategies for inhibiting the effects of thrombin
-
Harker L.A. Strategies for inhibiting the effects of thrombin. Blood Coagul and Fibrinolysis. 5:1994;S47-S58.
-
(1994)
Blood Coagul and Fibrinolysis
, vol.5
, pp. 47-S58
-
-
Harker, L.A.1
-
31
-
-
0018867789
-
Possible significance of small numbers of functional platelets in a population of aspirin-treated platelets in vitro and in vivo
-
Cerskus A.L., Ali M., Davies B.J., McDonald J.W.D. Possible significance of small numbers of functional platelets in a population of aspirin-treated platelets in vitro and in vivo. Thromb Res. 18:1980;389-397.
-
(1980)
Thromb Res
, vol.18
, pp. 389-397
-
-
Cerskus, A.L.1
Ali, M.2
Davies, B.J.3
McDonald, J.W.D.4
-
32
-
-
0344348978
-
Sites of elimination and pharmacokinetics of recombinant I-131-lepirudin in baboons
-
Meiring S.M., Lotter M.G., Badenhorst P.N., Bucha E., Novak G., Kotzé H.F. Sites of elimination and pharmacokinetics of recombinant I-131-lepirudin in baboons. J Pharm Sci. 88:1999;523-529.
-
(1999)
J Pharm Sci
, vol.88
, pp. 523-529
-
-
Meiring, S.M.1
Lotter, M.G.2
Badenhorst, P.N.3
Bucha, E.4
Novak, G.5
Kotzé, H.F.6
|